Document is current
Any future updates will be listed below
-
Authors
Weiss, Glen J.
Loftus, Joseph C.
Mallery, David W.
Tran, Nhan L.
-
Funding
Funding for this research was provided by:
International Genomics Consortium
- License Information
-
More Information
Article History
Received: 13 February 2026
Accepted: 30 April 2026
First Online: 4 May 2026
Declarations
:
: The authors declare the following competing interests. GJW has served as a paid consultant for Bantam Pharmaceutical (stock options and travel support), mbiomics (stock options and travel support), Angiex (stock options and travel support), Imaging Endpoints II, International Genomics Consortium, Maverix Medical, Quibim (stock options), SUN Pharma, Kymera, Accent Therapeutics, and is an unpaid consultant for Avenio AI. GJW has employment and other business ownership interests with MiRanostics Consulting. GJW holds equity interests in Agenus, Circulogene, and Vivia Oncology. DWM has an employment interest in the International Genomics Consortium, has an employment and equity interest in Maverix Medical, holds an equity interest in Vivia Oncology and has an equity interest at Reference Medicine. JCL and NLT served as paid scientific advisors for International Genomics Consortium.
: All animal experiments were conducted in accordance with institutional guidelines and approved protocols, and were performed by accredited contract research organizations in compliance with applicable ethical regulations. No human subjects were involved in this study.
